Mackenzie Financial Corp Repligen Corp Transaction History

Mackenzie Financial Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $45,152 - $61,315	-278 Reduced 15.27%	1,542 $261,000
Q3 2022 Oct 07, 2022	SELL	$160.42 - $256.21 $142,292 - $227,258	-887 Reduced 32.77%	1,820 $341,000
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $273,341 - $365,322	-1,943 Reduced 41.78%	2,707 $440,000
Q4 2019 Feb 13, 2020	SELL	$73.84 - $93.08 $5.75 Million - $7.24 Million	-77,810 Reduced 94.36%	4,650 $430,000
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $130,305 - $162,367	-1,700 Reduced 2.02%	82,460 $6.32 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $4.16 Million - $6.59 Million	76,730 Added 1032.71%	84,160 $7.23 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $367,413 - $466,604	7,430 New	7,430 $439,000
Q2 2018 Aug 13, 2018	SELL	$35.26 - $47.04 $33.4 Million - $44.5 Million	-946,366 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $194,796 - $234,801	6,300 Added 0.67%	946,366 $34.2 Million
Q4 2017 Feb 13, 2018	BUY	$32.53 - $38.92 $26.1 Million - $31.2 Million	802,848 Added 585.09%	940,066 $34.1 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $5.07 Million - $6.32 Million	137,218	137,218 $5.26 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.